ICPT — Intercept Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $793.52m
- $713.07m
- $285.71m
U.S. RESEARCH ROUNDUP-Digitalbridge Group, Huntington Ingalls Industries, Workday
U.S. RESEARCH ROUNDUP-Docusign, Immunovant, Liberty Energy
U.S. STOCKS ON THE MOVE-Amazon, United Parcel Service, Nike
U.S. STOCKS ON THE MOVE-BullFrog AI, Soleno,
Deals of the day-Mergers and acquisitions
Intercept Pharma jumps on buyout by Italy's Alfasigma
Brief: Intercept Pharmaceuticals Says If Deal Terminated Under Certain Circumstances, Co Required To Pay Alfasigma Termination Fee Equal To $34 Million
Italy's Alfasigma to buy drugmaker Intercept for nearly $800 mln (updated)
Italy's Alfasigma to buy drugmaker Intercept for nearly $800 mln
Brief: Alfasigma To Acquire Intercept Pharmaceuticals For $19.00 Per Share In Cash
U.S. STOCKS ON THE MOVE-Waters Corp, Parson, Xylem
U.S. STOCKS ON THE MOVE-e.l.f. Beauty, Yum Brands, Nikola
U.S. STOCKS ON THE MOVE-Vertiv Holdings, Emerson Electric, Intercept Pharma
Intercept Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Intercept Pharma rises as Q2 revenue beat estimates
Brief: Intercept Pharmaceuticals Q2 Sales USD 83.7 Million Vs. IBES Estimate USD 79.6 Million
Intercept Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cryoport, cybersecurity firms, China ADRs
Intercept rises as HC Wainwright upgrades on liver disease drug potential